Last $49.26 USD
Change Today -0.08 / -0.16%
Volume 87.7K
GB On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

greatbatch inc (GB) Snapshot

Open
$49.67
Previous Close
$49.34
Day High
$49.95
Day Low
$49.15
52 Week High
07/30/14 - $51.64
52 Week Low
02/10/14 - $40.02
Market Cap
1.2B
Average Volume 10 Days
145.5K
EPS TTM
$2.41
Shares Outstanding
25.0M
EX-Date
--
P/E TM
20.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for GREATBATCH INC (GB)

Related News

No related news articles were found.

greatbatch inc (GB) Related Businessweek News

View More BusinessWeek News

greatbatch inc (GB) Details

Greatbatch, Inc. is engaged in implantable medical and electrochem solutions businesses. It operates in two segments: Greatbatch Medical and QiG Group. The company designs and manufactures medical devices and components for the cardiac, neuromodulation, orthopaedics, portable medical, vascular and energy markets, and others. The company offers cardiac and neuromodulation products, including batteries, capacitors, filtered and unfiltered feedthroughs, engineered components, implantable stimulation leads, and enclosures used in implantable medical devices; orthopaedics products, such as hip and shoulder joint reconstruction implants, bone plates and spinal devices, and instruments and delivery systems used in hip and knee replacement, trauma fixation, extremity, and spine surgeries. It also provides vascular products comprising introducers, steerable sheaths, and catheters that deliver minimally invasive therapies for coronary and neurovascular disease, peripheral vascular disease, interventional radiology, vascular access, atrial fibrillation, and interventional cardiology, as well as products for medical imaging and drug and pharmaceutical delivery. In addition, Greatbatch offers customized battery power and management systems, charging and docking stations, and power supplies; non-rechargeable and rechargeable batteries, which are used in the portable medical, energy, military, and environmental markets; and rechargeable battery packs, such as electronics, charging, and battery management systems that are used in critical and life-saving applications, including automated external defibrillators, ventilators, powered surgical instruments, portable oxygen concentrators, and others. The company serves large multi-national original equipment manufacturers. Greatbatch, Inc. sells its products in the United States, Puerto Rico, Belgium, the United Kingdom, Ireland, and internationally. The company was founded in 1970 and is headquartered in Frisco, Texas.

3,385 Employees
Last Reported Date: 03/4/14
Founded in 1970

greatbatch inc (GB) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $616.3K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $366.1K
Executive Vice President of Global Operations
Total Annual Compensation: $328.3K
Principal Accounting Officer, Vice President ...
Total Annual Compensation: $301.6K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $242.9K
Compensation as of Fiscal Year 2013.

greatbatch inc (GB) Key Developments

Greatbatch, Inc. Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 08:00 AM

Greatbatch, Inc. Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 08:00 AM. Venue: The Westin Grand Central, New York, New York, United States.

Greatbatch, Inc. Presents at Northcoast Fall Management Forum, Nov-05-2014

Greatbatch, Inc. Presents at Northcoast Fall Management Forum, Nov-05-2014 . Venue: Grand Hyatt Hote, New York, New York, United States.

Greatbatch, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended October 3, 2014; Provides Earnings Guidance for the Full Year of 2014

Greatbatch, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended October 3, 2014. For the quarter, the company reported sales of $171,699,000 compared to $167,730,000 a year ago. Operating income was $16,183,000 compared to $17,002,000 a year ago. Income before provision for income taxes was $18,900,000 compared to $15,544,000 a year ago. Net income was $14,012,000 or $0.54 per diluted share compared to $11,071,000 or $0.44 per diluted share a year ago. Adjusted operating income was $22,446,000 compared to $22,012,000 a year ago. Adjusted net income was $16,509,000 or $0.64 per diluted share compared to $14,475,000 or $0.57 per diluted share a year ago. Adjusted EBITDA was $37,741,000 compared to $30,817,000 a year ago. The decrease in GAAP operating income was primarily due to increased SG&A and consolidation and optimization costs partially offset by higher gross profit. Cash flows provided by operating activities for the third quarter of 2014 were $28.2 million compared to $24.7 million for the 2013 third quarter. This quarter over quarter increase was primarily due to the $8.0 million estimated tax payment made in the third quarter of 2013 in connection with the retirement of convertible subordinated notes partially offset by increased working capital levels in order to support their growth strategy. Third quarter capital expenditures were $4.1 million compared to $3.4 million a year ago. For the nine months, the company reported sales of $518,061,000 compared to $487,326,000 a year ago. Operating income was $58,246,000 compared to $48,476,000 a year ago. Income before provision for income taxes was $59,093,000 compared to $37,621,000 a year ago. Net income was $41,282,000 or $1.60 per diluted share compared to $26,486,000 or $1.06 per diluted share a year ago. Adjusted operating income was $68,556,000 compared to $63,515,000 a year ago. Adjusted net income was $45,866,000 or $1.77 per diluted share compared to $39,129,000 or $1.56 per diluted share a year ago. Adjusted EBITDA was $96,412,000 compared to $90,173,000 a year ago. Capital expenditures were $16.0 million compared to $15.0 million a year ago. Operating cash flow was $54.7 million, positively impacted by a stronger operating income and lower tax payments in 2013. The company is raising 2014 full year revenue and adjusted diluted earnings per share guidance range to $695 million to $705 million and $2.32 to $2.38 per share, respectively. It is important to note that the midpoint of guidance would result in approximately 5% organic constant currency growth and two times that amount for adjusted operating income growth in comparison to 2013, which is consistent with long-term strategic growth objectives. The company expects adjusted effective tax rate for the remainder of the year 2014 will approximate 30% to 32%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GB:US $49.26 USD -0.08

GB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Analogic Corp $86.63 USD +0.20
Astronics Corp $53.84 USD +1.47
Ducommun Inc $26.58 USD +0.61
Newport Corp $19.52 USD +0.12
Universal Electronics Inc $64.82 USD +0.85
View Industry Companies
 

Industry Analysis

GB

Industry Average

Valuation GB Industry Range
Price/Earnings 25.0x
Price/Sales 1.8x
Price/Book 2.1x
Price/Cash Flow 24.1x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GREATBATCH INC, please visit www.greatbatch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.